Alterations affecting genes of the IFNγ signalling cascade were more frequent in metastatic samples compared with primary tumours (Fig. 5b) and were detectable in metastases from patients receiving neo-adjuvant IFNα and from patients without treatment (Supplementary Data 1). This evidence concerns the gene IFNG and neoplasm.